As is observed, the present study also found a significant association of the FGFR2 rs1219648 polymorphism with breast cancer risk in all determined genetic models, including additive model 1 (aOR = 2.87, p < 0.0001), additive model 2 (aOR = 5.62, p < 0.0001), the dominant model (aOR = 2.87, p < 0.0001), the recessive model (OR = 4.04, p = 0.0001), and alleles (OR = 2.16, p < 0.0001). The gene discussed is FGFR2; the disease is breast carcinoma.